As it tries to close its biggest deal ever -- a $33bn acquisition of Perrigo -- Mylan is now also dealing with an FDA warning letter citing cGMP violations tied to three of its manufacturing facilities in India.
The US Food and Administration says that a new project examining the interaction between its review and facilities inspection arms will help improve inter-departmental communication, particularly during pre-approval inspections (PAI)
A technology partnership between ARTEL and Caliper Life Sciences
aims to enhance automated liquid delivery standards improving
laboratory data integrity. The collaboration aims to manufacture
technology to a level that is outlined...